P.C | Jotup

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Anavex, and Innoviz and Encourages Investors to Contact the Firm

Retrieved on:

Saturday, March 23, 2024

Bitcoin, Research, Bankruptcy, Patient, Defendant, News, Data mining, Rett syndrome, Complaint, Hut 8, P.C, Clinical trial, MCI, Radar, Mergers and acquisitions, Cryptocurrency

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points:

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
Additional information about each case can be found at the link provided.
In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
For more information on the Innoviz class action go to: https://bespc.com/cases/INVZ

B. RILEY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against B. Riley Financial, Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Saturday, March 23, 2024

FRG, Telephone, District court, Defendant, Loss, Complaint, P.C, Court, Person, Security (finance)

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against B. Riley Financial, Inc. (“B.

Key Points:

NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against B. Riley Financial, Inc. (“B.
Investors have until March 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
According to the filed complaint, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects.

ADM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Archer-Daniels-Midland Company and Encourages Investors to Contact the Firm

Retrieved on:

Saturday, March 23, 2024

Growth, FY, District court, Telephone, Defendant, News, Q4, ADM, P.C, Court, Person

Investors have until March 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until March 25, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
As ADM was aggressively acquiring companies to expand its capabilities in Nutrition, investors were under the impression that the segment was growing rapidly.
On January 21, 2024, ADM announced that it had placed its CFO Vikram Luther on leave effective immediately.
As a result, ADM delayed its Q4 and FY 2023 earnings release and withdrew its outlook for the Nutrition segment.

ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. is Investigating AdaptHealth Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

Sleep apnea, Diabetes, Telephone, Patient, Insurance, Complaint, P.C, Medicare, CMS, Cryptocurrency

Our investigation concerns whether the board of directors of AdaptHealth have breached their fiduciary duties to the company.

Key Points:

Our investigation concerns whether the board of directors of AdaptHealth have breached their fiduciary duties to the company.
AdaptHealth is a supplier of home medical equipment for chronic health conditions including diabetes, sleep apnea, and wound care.
AdaptHealth sells medical devices directly to patients, and then bills patients’ insurance providers, including the Centers for Medicare and Medicaid Services (“CMS”).
To facilitate this scheme, AdaptHealth and certain of its senior executives made numerous false and misleading statements to investors during the Class Period.

CHEMOURS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against The Chemours Company and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

Investors have until May 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until May 20, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
After the market closed on February 9, 2023, Chemours announced its fourth quarter and full year 2022 financial results.
Chemours reported quarterly and year-to-date Free Cash Flow metrics in connection with each of the Company’s quarterly financial results throughout the remainder of the Class Period.
Prior to and during the Class Period, Chemours also set and publicized certain criteria for executive compensation.

MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

Telephone, MASI, Defendant, P.C, Class, Fraud, Cryptocurrency

Our investigation concerns whether the board of directors of Masimo have breached their fiduciary duties to the company.

Key Points:

Our investigation concerns whether the board of directors of Masimo have breached their fiduciary duties to the company.
Masimo’s stock price fell in response to the corrective event on July 17, 2023, as alleged supra.
In particular, on July 17, 2023, Masimo reduced the lower end of full year revenue guidance for the healthcare business to $1.30 billion from $1.45 billion.
The Company also announced a reduction in annual revenue guidance for the non-healthcare business to $800 million to $850 million from $965 million to $995 million.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Innodata, Fox Factory, Lantronix, and Palo Alto Networks and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.

Key Points:

Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021.
On this news, the price of Innodata common stock declined by $3.74 per share, or approximately 30.5%, on February 15, 2024.
The complaint further alleges that when these misleading statements and omissions about Fox Factory’s business reached the market, investors were harmed significantly.
For more information on the Palo Alto Networks class action go to: https://bespc.com/cases/PANW

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cassava, NYCB, Amylyx, and InMode and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

The Company's lead therapeutic drug candidate is PTI-125 (or "simufilam"), a small molecule drug for the proposed treatment of Alzheimer's disease.

Key Points:

The Company's lead therapeutic drug candidate is PTI-125 (or "simufilam"), a small molecule drug for the proposed treatment of Alzheimer's disease.
However, in response, Cassava denied the allegations in the Citizen Petition and instead touted the effectiveness of simufilam and the efficacy of the Company's research programs.
On this news, Cassava's stock price fell $2.68 per share, or 15.28%, to close at $14.86 per share on October 13, 2023.
For more information on the InMode class action go to: https://bespc.com/cases/INMD

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nextdoor, and Snowflake and Encourages Investors to Contact the Firm

Retrieved on:

Friday, March 22, 2024

Growth, Shareholder, COVID-19, Internet, Snowflake Inc., News, Acquisition, IPO, Networking hardware, SNOW, ARPU, P.C, Video game

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points:

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
On this news, the price of Nextdoor Class A common stock fell approximately 11%, further damaging investors.
which lowered credit consumption.” On this news, the price of Snowflake Class A common stock fell nearly 28% over several trading sessions, damaging investors.
For more information on the Snowflake class action go to: https://bespc.com/cases/SNOW

NBH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Next Bridge Hydrocarbons, Inc. and Encourages Investors to Contact the Firm

Retrieved on:

Thursday, March 21, 2024

NBH, Telephone, District court, Metamaterial, Meta, P.C, Court, Person

Investors have until May 14, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points:

Investors have until May 14, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
The complaint alleges that NBH filed a registration statement in connection with its spin-off from Meta Materials that contained false and/or materially misleading statements.
The statements at issue concern the value of the Company's oil and gas assets and NBH's transactions with related parties.
The complaint alleges that these false and/or materially misleading statements violated the Securities Act of 1933 and, consequently, damaged shareholders who received NBH shares in conjunction with the spin-off.